Development System
CCR5_site_16 | SCGE Toolkit
Targets endogenous human locus
| 10000000125 |
| CCR5_site_16 |
| lab IVT |
| CCR5 |
| human |
| Targets endogenous human locus |
| SpyCas9 |
|
| GTATGGAAAATGAGAGCTGC |
| GTATGGAAAATGAGAGCTGCNGG |
| hg38/chr3:46373431-46373454 |
|
| GUAUGGAAAAUGAGAGCUGC |
| 20 |
| none |
|
| AGGTACCTGGCTGTCGTCCATGCT |
| AGATGACCATGACAAGCAGCGGCA |
| Ivt Construct Source | Addgene |
| Vector Id | 153997 |
| Vector Name | pCRL01 |
| Vector Description | Plasmid for single guide RNA IVT |
| Vector Type | plasmid |
| Annotated Map | addgene-plasmid-153997-sequence-304516 |
|
|
| Detection Method | No. of sites detected |
|---|
| Change-seq |
510
|
| Guide-seq |
2
|
|
|
| Publication Title |
|
CHANGE-seq reveals genetic and epigenetic effects on CRISPR-Cas9 genome-wide activity. NCBI |
This Guide: CCR5_site_16 is being used ...
| Project |
Initiative |
Contact PI |
|
|
|
Biological Effects |
Shengdar Q Tsai, PhD
(St. Jude Children's Research Hospital) |
|